Lysentech Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $8.18M

  • Investors
  • 6

Lysentech General Information

Description

Operator of a drug development company intended to develop antibiotics that control antibiotic-resistant bacteria. The company's core technologies include the development of antibacterials using bacteriophages and phage-derived endolysins and the development of target-specific oncolytic bacteriophages, enabling physicians to receive anticancer drugs that target and kill cancer cells using bacteriophages.

Contact Information

Website
lysentech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 215, Natural Science Building
  • 81 Oedae-ro, Cheoin-gu
  • Yongin, Gyeonggi-do
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Room 215, Natural Science Building
  • 81 Oedae-ro, Cheoin-gu
  • Yongin, Gyeonggi-do
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lysentech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 22-Dec-2021 $8.18M Completed Startup
2. Accelerator/Incubator 01-Sep-2019 Completed Startup
1. Early Stage VC 01-Jan-2019 Completed Startup
To view Lysentech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lysentech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug development company intended to develop antibiotics that control antibiotic-resistant bacteria. The c
Drug Discovery
Yongin, South Korea
4 As of 2025

Morrisville, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lysentech Competitors (1)

One of Lysentech’s competitors is Locus Biosciences, a Venture Capital-Backed company based in Morrisville, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Locus Biosciences Venture Capital-Backed Morrisville, NC
You’re viewing 1 of 1 competitors. Get the full list »

Lysentech Patents

Lysentech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024531962-A Novel polypeptide and antibiotic against gram-negative bacteria containing the same Pending 19-Aug-2021
CA-3229593-A1 Novel polypeptides and antibiotics against gram-negative bacterium comprising the same Pending 19-Aug-2021
EP-4137568-A1 Novel polypeptides and antibiotics against gram-negative bacterium comprising the same Inactive 19-Aug-2021
WO-2023022546-A1 Novel polypeptides and antibiotics against gram-negative bacterium comprising the same Inactive 19-Aug-2021
US-12102667-B2 Polypeptides and antibiotics against gram-negative bacterium comprising the same Active 19-Aug-2021 A61K38/47
To view Lysentech’s complete patent history, request access »

Lysentech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lysentech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
J Curve Investment Venture Capital Minority
Kingo Investment Partners Venture Capital Minority
Medytox Corporation Minority
Partners Investment Venture Capital Minority
Tech Incubator Program for Startup Accelerator/Incubator Minority
You’re viewing 5 of 6 investors. Get the full list »

Lysentech FAQs

  • When was Lysentech founded?

    Lysentech was founded in 2019.

  • Where is Lysentech headquartered?

    Lysentech is headquartered in Yongin, South Korea.

  • What is the size of Lysentech?

    Lysentech has 4 total employees.

  • What industry is Lysentech in?

    Lysentech’s primary industry is Drug Discovery.

  • Is Lysentech a private or public company?

    Lysentech is a Private company.

  • What is Lysentech’s current revenue?

    The current revenue for Lysentech is .

  • How much funding has Lysentech raised over time?

    Lysentech has raised $8.18M.

  • Who are Lysentech’s investors?

    J Curve Investment, Kingo Investment Partners, Medytox, Partners Investment, and Tech Incubator Program for Startup are 5 of 6 investors who have invested in Lysentech.

  • Who are Lysentech’s competitors?

    Locus Biosciences is a competitor of Lysentech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process